Optimization of the Ocular Surface Prior to Cataract Surgery Using PROKERA

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

January 21, 2025

Study Completion Date

January 21, 2025

Conditions
CataractDry Eye SyndromesCataract SenileDry Eye
Interventions
DEVICE

PROKERA

Amniotic membrane is the sac that encloses the baby during pregnancy. Amniotic membrane has been used to treat many ocular (eye) diseases and repair ocular surface damage. PROKERA contains amniotic membrane fastened between a ring system and can be worn in the eye like a contact lens. PROKERA is a medical device that was cleared by the United States food and drug administration (FDA) in 2003.

Trial Locations (1)

66061

Grin Eye Care, Olathe

All Listed Sponsors
lead

Jeff Wongskhaluang

OTHER

NCT05148507 - Optimization of the Ocular Surface Prior to Cataract Surgery Using PROKERA | Biotech Hunter | Biotech Hunter